In summary, the CLCA1/TMEM16A/Cl– current axis is an important contributing mechanism in diabetic kidney injury that is triggered by deficiency in constitutive synthesis of H2S. Components of this axis, H2S, CLCA1, and TMEM16A, are attractive drug targets deserving further exploration in DKD. Here, CLCA1 is linked to diabetic kidney disease.